Dramatic Metabolic Response to Dual ICI With Chemotherapy in Low PD‐L1 NSCLC Case

Dramatic Metabolic Response to Dual ICI With Chemotherapy in Low PD‐L1 NSCLC Case

ABSTRACT Despite low PD‐L1 (Programmed Death‐ligand 1) expression, this patient exhibited a dramatic positron emission tomography‐computed tomography response to dual immune checkpoint inhibitors with chemotherapy. This case highlights the potential benefits of combination therapy beyond traditional...

Full description

Saved in:
Bibliographic Details
Main Authors: Toshikazu Kumasa, Akina Nigi, Keisuke Iwamoto, Hidetoshi Itani, Shigeto Kondou
Format: Article
Language:English
Published: Wiley 2025-03-01
Series:Respirology Case Reports
Subjects:
ipilimumab
low‐PD‐L1expression
lung cancer
nivolumab
PET‐CT
Online Access:https://doi.org/10.1002/rcr2.70150
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT Despite low PD‐L1 (Programmed Death‐ligand 1) expression, this patient exhibited a dramatic positron emission tomography‐computed tomography response to dual immune checkpoint inhibitors with chemotherapy. This case highlights the potential benefits of combination therapy beyond traditional PD‐L1‐based treatment selection.
ISSN:2051-3380

Similar Items